Objectives: Inhibition of the renin-angiotensin system (RAS) has lead to important pharmacological tools to treat atherosclerosis and other cardiovascular diseases. Angiotensin-converting enzyme 2 (ACE2) has emerged as a central negative regulator of RAS by degrading angiotensin (Ang) II to generate Ang-(1-7). We hypothesized that ACE2 would exert beneficial effects on myocardial injury in apolipoprotein E-knockout (ApoEKO; ApoE -/-) mice. Methods: In this work, we used 3-month-old wild-type, ApoEKO, and ACE2/ApoE double-KO mice. We implanted subcutaneously mini-osmotic pumps with Ang II (1.5 mg/kg/d) or saline for 2 weeks in the ApoE -/mice which were then treated with recombinant human ACE2 (hrACE2; 2 mg/kg/d). We characterized the functional, structural and molecular changes in mice hearts. Results: Compared with the ApoE -/mice, ACE2 deficiency triggered greater increases in cardiac expression of CTGF and phosphorylated level of pERK1/2 in the ACE2/ApoE double-KO mice (n¼5-6; P<0.01, respectively). These changes were associated with exacerbation of myocardial ultrastructure injury and greater activation of inflammatory factors including CCL2, fractalkine (FKN), interleukin 1b (IL1b), IL17, and ICAM1. Ang II infusion resulted in a predicted pressor response and marked increases in cardiac expression of CCL2, FKN, IL1b, IL17, and ICAM1 in the ApoE -/mice with activation of the CTGF and ERK signaling (n¼5-6; P<0.05 or P<0.01, respectively). Consistent with induction of inflammation, Ang II infusion led to elevation of superoxide production and severe ultrastructure injury in hearts of the ApoE -/mice with increased cardiac NADPH oxidase activity and elevated circulating Ang II levels. Notably, treatment with hrACE2 strikingly alleviated oxidative stress and attenuated ultrastructure injury in the hearts of Ang II-treated ApoE -/mice linked with reduction of NADPH oxidase activity and abolishment of expression of CTGF, P-ERK1/2, CCL2, ICAM1, FKN, IL1b and IL17 (n¼4-5; P<0.05 or P<0.01, respectively). However, there were no changes in p38-MAPK and CX3CR1 levels among groups (n¼4-6; P>0.05; respectively). Conclusions: Absence of ACE2 triggers greater increases in myocardial inflammation and oxidative stress in the ACE2/ApoE double-mutant mice with exacerbation of myocardial ultrastructure injury. Conversely, ACE2 overexpression alleviates Ang IImediated inflammation and ultrastructure injury in hearts of the ApoE-deficient mice with suppression of superoxide generation and the CTGF-ERK signaling activation. Strategies aimed at enhancing ACE2 action may have important therapeutic potential for cardiac disorders.
Objectives: Diastolic heart failure (DHF) patients had higher left ventricular (LV) stiffness, optimal therapy for DHF has not been determined. The efficiency of the angiotensin receptor blocker (ARB) on DHF treatment has been controversy. Accordingly, this preliminary study was to investigate the effect of the different doses of candesartan on the early DHF to prevent passive LV stiffness in diabetic rabbits. Methods: Sixty rabbits were randomly divided into 4 groups (n¼15 in each group). Group 1 (G1) and Group 2 (G2) were assigned to the following candesartan cilexetil (G1: 1mg/kg/d and G2: 5mg/kg/d) treatment on the 4th day after injection of alloxan of a 4-wk pacing schedule. The other rabbits were assigned to the diabetic group (GD, no medicine treatment of alloxan injection) and control group (GC, normal rabbits). LV function was measured by echocardiography. LV passive stiffness was evaluated by cardiac morphology, myocardial deposition of collagen and advanced glycation end products (AGEs) through electron microscopy, HE staining method, Immunohistochemical method, and Quantitative histomorphometry. Cardiac total titin and titin N2B/N2BA ratio were measured by gel electrophoresis, and total titin mRNA level expression was assessed by Quantitative real-time PCR. Results: All the diabetic rabbits were identified that LV diastolic dysfunction with preserved systolic function measured by echocardiography through 4 weeks. Collagen solubility percentage (%) (G1, 46.08AE3.05; G2, 48.54AE3.04; GD, 40.43AE2.75 vs. GC, 50.22AE2.99; P<0.05), Immunohistochemistry CML scoring (score/mm2) (G1, 29.52AE4.22; G2, 24.8AE2.97; GD, 40.89AE3.01 vs. GC, 15.59AE1.88; P<0.05) and the expression of titin mRNA (G1, 4.58AE0.47; G2, 5.15AE0.63; GD, 3.55AE0.58 vs. GC, 1AE0.2; P<0.05) were differ significantly among these four groups, but there were not differ significantly between G1 and G2 (P>0.05), however, differ significantly between ARB treatment groups and diabetic group in the Immunohistochemistry CML scoring. In all diabetic rabbits, there was not investigated of interstitial fibrosis by Masson's trichrome stain. Total titin amount and N2B/N2BA ratio by method of Quantitative protein analysis were no differences between all the groups. Conclusions: ARB therapy which is independent of its dosage tailored to reducing the deleterious effects of the CML-AGEs deposited in diabetic cardiomyopathy of early stage was being experiment and providing evidences of possible underlying mechanisms of DHF.
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A Novel Haplotype in the GOSR2 Gene is Associated With Coronary Artery Disease in Chinese Han population Objectives: The Golgi SNAP Receptor Complex Member 2 (GOSR2) gene is Golgiassociated soluble factor attachment receptor (SNARE) protein. Some SNPs in GOSR2 gene are found to be associated with coronary artery disease (CAD) and myocardial infarction (MI). The aim of the present study was to assess the association between the human GOSR2 gene and coronary artery disease using a haplotype-based case-control study in Chinese Han population. Methods: A total of 283 CAD patients and 280 controls were genotyped for the five single-nucleotide polymorphisms (SNPs) used as genetic markers for the human GOSR2 gene (rs197932, rs3785889, rs197922, rs17608766, and rs16941382). Data were analyzed for three separate groups: the total subjects, men, and women. Results: In the recessive model of re197932 in men, there was statistical difference in CC genotype and TT+CT genotypes distribution between CAD and control group. In total subjects, the overall distribution of the haplotypes established by rs3785889-rs16941382 was significantly different between the CAD patients and the control subjects. For the total subjects, the frequency of the G-T haplotype established by rs3785889-rs16941382 was significantly higher for the CAD patients as compared to the control subjects (P¼0.009). Multiple logistic regression analysis also revealed that the people with G-T haplotype established by rs3785889-rs16941382 (homozygote) were found to have significantly higher chance of suffering from CAD than the ones without this haplotype after adjustment for the major risk factors (OR¼1.887, P¼0.007).
Conclusions:
The results of this study indicate that the G-T haplotype established by rs3785889-rs16941382 may be a useful genetic marker for CAD patients in Chinese Han population.
GW25-e2292
The effects of Angiotensin-(1-7) /Mas/PI3K/Akt/NO axis in acute atrial tachycardia canine model and the possible role of atrial natriuretic peptide Jun Zhao, Enzhao Liu Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University Objectives: To investigate the effects of Angiotensin-(1-7) [Ang-(1-7)] signaling pathway on atrial electrical remodeling in rapid atrial pacing canine model and the possible role of atrial natriuretic peptide (ANP). Methods: Thirty-five dogs were assigned to seven groups randomly. There are sham group, paced control group, paced + Ang-(1-7) group, paced + Ang-(1-7) + A-779 group, paced + Ang-(1-7) + API-2 group, paced + Ang-(1-7) + wortmannin group, and paced + Ang-(1-7) + L-NAME group, 5 dogs in each group. Rapid atrial pacing at 600 bpm was maintained for 2 hours except the animals from the sham group. During the pacing, Ang-(1-7) (6mg$kg -1 $h -1 ), A-779 (Mas inhibitor, 5.83mg$kg -1 $h -1 ), API-2 (Akt inhibitor, 2.14mg$kg -1 $h À1 ), wortmannin (PI3K inhibitor, 2.86mg$kg -1 $h -1 ) or L-NAME (NO synthase inhibitor, 180mg$kg -1 $h -1 ) were given intravenously, respectively. Electrophysiological parameters including atrial effective refractory periods (ERPs), inducibility and duration of atrial fibrillation (AF) under different basic pacing cycle length (300, 250, and 200 ms) were measured. Following electrophysiological study, ANP concentration of the left atrium was detected. Results: After atrial pacing for 2 hours, the atrial ERPs at 6 sites were shortened with the increase in inducibility and duration of AF in paced control group (P<0.05, vs sham). ANP concentration of the left atrium also increased in paced control group (P<0.05, vs sham). The shortening of atrial ERPs, and the increasing of inducibility and duration of AF induced by atrial pacing were attenuated by Ang-(1-7) treatment.
JACC Vol 64/16/Suppl C j October 16-19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine C1
